Engineered Bacteria Succinate Yield Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing succinate and other 4-carbon dicarboxylic acids through fermentation are inefficient, resulting in low yields and high production costs due to the production of unwanted byproducts and energy-intensive processes, making them non-competitive with petrochemically derived succinate.
Innovation Solution
Engineered bacteria with disrupted genes for lactate, acetate, and ethanol production, coupled with the overexpression of NAD+-dependent formate dehydrogenase and pyruvate carboxylase, are used to drive the Krebs cycle through the glyoxylate cycle, reducing byproduct formation and increasing succinate yield by optimizing carbon flux and NADH availability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional fermentation methods are used to produce succinate, then production can proceed with existing bacterial strains, but the yield is low and byproduct formation is high
Solution Approach 1:
The patent removes harmful byproduct formation pathways by disrupting genes encoding enzymes for acetate, lactate, and ethanol production. This extraction of unwanted metabolic pathways redirects carbon flux exclusively toward succinate production, eliminating substance loss to byproducts while maintaining high succinate yield.
Solution Approach 2:
The patent alters metabolic parameters by overexpressing key enzymes in the Krebs cycle and glyoxylate shunt, including isocitrate lyase and malate synthase. These parameter changes in enzyme activity and metabolic flux redirect carbon flow to maximize succinate production while minimizing byproduct formation.
2Productivity
If metabolic engineering is applied to increase succinate levels, then productivity can be improved, but the process complexity increases
Solution Approach 1:
The patent segments the metabolic engineering approach into distinct functional modules: (1) disruption of byproduct pathways, (2) overexpression of Krebs cycle enzymes, and (3) activation of the glyoxylate shunt. This segmentation allows systematic optimization of each module independently while managing overall process complexity.
Solution Approach 2:
The engineered bacterial strain performs multiple functions simultaneously: it maintains aerobic respiration, activates the glyoxylate shunt for carbon conservation, overexpresses Krebs cycle enzymes for enhanced flux, and redirects all carbon toward succinate production. This multi-functionality achieves high productivity through integrated metabolic pathways.
3Quantity of substance
If glucose is fermented to produce carboxylic acids, then renewable feedstock utilization is achieved, but most glucose is converted to byproducts rather than desired product
Solution Approach 1:
The patent converts the harmful effect of byproduct formation into a benefit by completely eliminating competing pathways. The disrupted byproduct pathways prevent energy loss, while the redirected carbon flux and NADH generation from these pathways are converted into beneficial drives for succinate production, achieving near-complete substrate conversion efficiency.
Solution Approach 2:
The patent establishes continuous useful action by maintaining active Krebs cycle flux and glyoxylate shunt operation throughout fermentation. The coordinated overexpression of multiple enzymes ensures continuous carbon flow through the succinate production pathway, maximizing substrate conversion efficiency without interruption or diversion to byproducts.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases succinate production rates and reduces byproduct formate levels, leading to lower production costs and improved efficiency in converting glucose to succinate, making the process more competitive with traditional methods.
Implementation Method 1
supplying increased NADH through overexpression of FDH
Implementation Method 2
driving the Krebs cycle through increased expression of PYC
Implementation Method 3
balancing the carbon flux through the fermentative pathway and the glyoxylate cycle
Data Source
AI summary
Improved bacteria for making succinate and other 4 carbon dicarboxylates from the Krebs cycle have modifications to reduce acetate, lactate, EtOH and formate, as well as turn on the glyoxylate shunt, produce more NADH and overexpress In one embodiment, the bacteria are ΔadhEΔldhAΔiclRΔack-pta plus PYC+ and NAD+-dependant FDH+.